Khan et al. linked the downregulated expression of the p53 gene in cancer patients to its epigenetic changes, including hypermethylation and deacetylation, shedding light on the role of these modifications in the progression of cervical cancer [134]. The gene discussed is TP53; the disease is cervical cancer.